MRC Clinical Trials Unit at UCL
90 High Holborn
2nd Floor
London
WC1V 6LJ
Email: mrcctu.archery@ucl.ac.uk
"NCI’s Center for Global Health’s Affordable Cancer Technologies (ACTs) Program supports research on tools and technologies, from their initial prototypes to clinical use. Through ACTs, NCI seeks to increase access to quality cancer prevention and care in settings with limited resources found across the globe. This blog features two ACTs grantees working on artificial intelligence (AI) solutions to aid in cancer diagnosis and treatment:
Drs. Aggarwal and Madabhushi give their perspectives on what it’s like developing, managing, and working across multinational borders to find new ways of using technology to address the diagnosis, treatment, and care of people living with cancer."
Read the full article on the NCI website here.
ARCHERY Study
MRC Clinical Trials Unit at UCL
90 High Holborn
2nd Floor
London
WC1V 6LJ
Email: mrcctu.archery@ucl.ac.uk